Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 064144/0596 | |
| Pages: | 3 |
| | Recorded: | 06/27/2023 | | |
Conveyance: | ASSIGNEE CHANGE OF ADDRESS |
|
Total properties:
9
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16824585
|
Filing Dt:
|
03/19/2020
|
Publication #:
|
|
Pub Dt:
|
09/24/2020
| | | | |
Title:
|
Combination Therapy Using a Chemokine Receptor 2 (CCR2) Antagonist and a PD-1 and/or PD-L1 Inhibitor
|
|
|
Patent #:
|
|
Issue Dt:
|
01/30/2024
|
Application #:
|
17219172
|
Filing Dt:
|
03/31/2021
|
Publication #:
|
|
Pub Dt:
|
10/07/2021
| | | | |
Title:
|
COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE USING CCR9 INHIBITOR AND ANTI-IL-23 BLOCKING ANTIBODIES
|
|
|
Patent #:
|
|
Issue Dt:
|
07/04/2023
|
Application #:
|
17338502
|
Filing Dt:
|
06/03/2021
|
Publication #:
|
|
Pub Dt:
|
04/21/2022
| | | | |
Title:
|
MACROCYCLIC IMMUNOMODULATORS
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17354003
|
Filing Dt:
|
06/22/2021
|
Publication #:
|
|
Pub Dt:
|
12/23/2021
| | | | |
Title:
|
METHODS OF TREATING CANCER USING HETEROARYL-BIPHENYL AMIDE DERIVATIVES
|
|
|
Patent #:
|
|
Issue Dt:
|
09/19/2023
|
Application #:
|
17460716
|
Filing Dt:
|
08/30/2021
|
Publication #:
|
|
Pub Dt:
|
06/09/2022
| | | | |
Title:
|
INDANE-AMINES AS PD-L1 ANTAGONISTS
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17576144
|
Filing Dt:
|
01/14/2022
|
Publication #:
|
|
Pub Dt:
|
02/09/2023
| | | | |
Title:
|
TRIARYL COMPOUNDS FOR TREATMENT OF PD-L1 DISEASES
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17694829
|
Filing Dt:
|
03/15/2022
|
Publication #:
|
|
Pub Dt:
|
01/26/2023
| | | | |
Title:
|
COMBINATION THERAPY USING A CHEMOKINE RECEPTOR 2 (CCR2) ANTAGONIST AND A PD-1/PD-L1 INHIBITOR
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17816614
|
Filing Dt:
|
08/01/2022
|
Publication #:
|
|
Pub Dt:
|
04/20/2023
| | | | |
Title:
|
2-OXINDOLE COMPOUNDS
|
|
|
Patent #:
|
|
Issue Dt:
|
10/24/2023
|
Application #:
|
17838400
|
Filing Dt:
|
06/13/2022
|
Publication #:
|
|
Pub Dt:
|
04/20/2023
| | | | |
Title:
|
IMMUNOMODULATOR COMPOUNDS
|
|
Assignee
|
|
|
ONE AMGEN CENTER DRIVE |
THOUSAND OAKS, CALIFORNIA 91320-1799 |
|
Correspondence name and address
|
|
AMGEN INC.
|
|
ONE AMGEN CENTER DRIVE
|
|
MAIL STOP 28-5-A
|
|
THOUSAND OAKS, CA 91320-1799
|
Search Results as of:
05/28/2024 12:14 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|